SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon - Quaterly Results

20 Jan 2022 Evaluate
The quarter ended December 2021 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 4730.00 millions.A slender decline of -22.73% was recorded to Rs. 255.00  millions from Rs. 330.00 millions in the corresponding previous quarter.Operating profit for the quarter ended December 2021 decreased to 710.00 millions as compared to 719.00 millions of corresponding quarter ended December 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 4730.00 4561.00 3.71 12205.00 15368.00 -20.58 20284.00 19884.00 2.01
Other Income 367.00 337.00 8.90 1264.00 1081.00 16.93 1502.00 2017.00 -25.53
PBIDT 710.00 719.00 -1.25 1610.00 3509.00 -54.12 4627.00 4877.00 -5.13
Interest 1.00 1.00 0.00 4.00 3.00 33.33 4.00 12.00 -66.67
PBDT 709.00 718.00 -1.25 1606.00 3506.00 -54.19 4623.00 6462.00 -28.46
Depreciation 276.00 260.00 6.15 801.00 781.00 2.56 1035.00 980.00 5.61
PBT 433.00 458.00 -5.46 805.00 2725.00 -70.46 3588.00 5482.00 -34.55
TAX 178.00 128.00 39.06 325.00 597.00 -45.56 783.00 1119.00 -30.03
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 255.00 330.00 -22.73 480.00 2128.00 -77.44 2805.00 4363.00 -35.71
Equity 6003.00 6000.00 0.05 6003.00 6000.00 0.05 6000.00 6000.00 0.00
PBIDTM(%) 15.01 15.76 -4.78 13.19 22.83 -42.23 22.81 24.53 -7.00

Biocon Share Price

380.55 -2.05 (-0.54%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×